KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Issued
Ratios

Quest Diagnostics (DGX) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $10.0 million.

  • Quest Diagnostics' Long-Term Debt Repayments rose 90000.0% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 4055.56%. This contributed to the annual value of $303.0 million for FY2024, which is 8356.83% down from last year.
  • As of Q3 2025, Quest Diagnostics' Long-Term Debt Repayments stood at $10.0 million, which was up 90000.0% from $401.0 million recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Long-Term Debt Repayments peaked at $688.0 million during Q2 2023, and registered a low of $1.0 million during Q1 2021.
  • For the 5-year period, Quest Diagnostics' Long-Term Debt Repayments averaged around $225.9 million, with its median value being $75.0 million (2023).
  • As far as peak fluctuations go, Quest Diagnostics' Long-Term Debt Repayments plummeted by 9987.52% in 2021, and later soared by 4170000.0% in 2023.
  • Over the past 5 years, Quest Diagnostics' Long-Term Debt Repayments (Quarter) stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then skyrocketed by 41700.0% to $418.0 million in 2023, then plummeted by 99.76% to $1.0 million in 2024, then surged by 900.0% to $10.0 million in 2025.
  • Its Long-Term Debt Repayments stands at $10.0 million for Q3 2025, versus $401.0 million for Q2 2025 and $600.0 million for Q1 2025.